American Financial Group, Inc. (AFGE) Trades at $26.20 After Triangle; Last Week Evolent Health, Inc. (EVH) Coverage

December 28, 2017 - By Danny Collins

Among 14 analysts covering Evolent Health (NYSE:EVH), 14 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Evolent Health had 34 analyst reports since August 7, 2015 according to SRatingsIntel. Robert W. Baird maintained the shares of EVH in report on Tuesday, October 31 with “Buy” rating. On Tuesday, March 29 the stock rating was initiated by FBR Capital with “Outperform”. The firm earned “Outperform” rating on Friday, January 13 by Wells Fargo. The firm has “Buy” rating by Cantor Fitzgerald given on Wednesday, August 9. Jefferies maintained Evolent Health, Inc. (NYSE:EVH) rating on Thursday, November 2. Jefferies has “Buy” rating and $28.0 target. Jefferies maintained the stock with “Buy” rating in Thursday, September 28 report. The stock of Evolent Health, Inc. (NYSE:EVH) has “Buy” rating given on Wednesday, September 20 by SunTrust. The rating was maintained by Jefferies on Friday, July 7 with “Buy”. Cantor Fitzgerald maintained Evolent Health, Inc. (NYSE:EVH) rating on Friday, November 10. Cantor Fitzgerald has “Buy” rating and $30.0 target. Jefferies maintained the stock with “Buy” rating in Monday, August 21 report. See Evolent Health, Inc. (NYSE:EVH) latest ratings:

11/12/2017 Broker: Canaccord Genuity Rating: Buy New Target: $27.0 Maintain
16/11/2017 Broker: Leerink Swann Rating: Buy New Target: $25.0 Maintain
10/11/2017 Broker: Cantor Fitzgerald Rating: Buy New Target: $30.0 Maintain
07/11/2017 Broker: Goldman Sachs Rating: Buy New Target: $16.0
02/11/2017 Broker: Jefferies Rating: Buy New Target: $28.0 Maintain
31/10/2017 Broker: Robert W. Baird Rating: Buy New Target: $25.0 Maintain
06/10/2017 Broker: Canaccord Genuity Rating: Buy New Target: $32.0 Maintain
28/09/2017 Broker: Robert W. Baird Rating: Outperform Old Target: $35 New Target: $25 Maintain
28/09/2017 Broker: Jefferies Rating: Buy New Target: $28.0 Maintain
24/09/2017 Broker: Robert W. Baird Rating: Buy New Target: $35.0 Maintain

American Financial Group, Inc. (AFGE) formed triangle with $27.25 target or 4.00% above today’s $26.20 share price. American Financial Group, Inc. (AFGE) has $9.04 billion valuation. The stock decreased 0.49% or $0.13 during the last trading session, reaching $26.2. About 17,815 shares traded or 98.34% up from the average. American Financial Group, Inc. (NYSE:AFGE) has declined 0.59% since December 28, 2016 and is downtrending. It has underperformed by 17.29% the S&P500.

The stock decreased 2.60% or $0.35 during the last trading session, reaching $13.1. About 871,183 shares traded. Evolent Health, Inc. (NYSE:EVH) has risen 80.60% since December 28, 2016 and is uptrending. It has outperformed by 63.90% the S&P500.

Evolent Health, Inc., through its subsidiary, Evolent Health LLC, provides healthcare delivery and payment solutions in the United States. The company has market cap of $1.01 billion. It operates as a managed services firm that supports integrated health systems in migration toward value care and population health management. It currently has negative earnings. The companyÂ’s services include providing clients with a population management platform, integrated data and analytics capabilities, pharmacy benefit management services, and comprehensive health plan administration services.